Severe early-onset colitis revealing mevalonate kinase deficiency

Pediatrics

Volumn 132, Issue 3, 2013, Pages

  Levy, Michael ^a   Arion, Alina ^b   Berrebi, Dominique ^a   Cuisset, Laurence ^c   Jeanne Pasquier, Corinne ^d   Bader Meunier, Brigitte ^e   Jung, Camille ^a,f  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b Department of Pediatrics   (France)

^c University Paris Descartes ^*  (France)

^d CAEN UNIVERSITY HOSPITAL   (France)

^e INSERM   (France)

^f CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

Anti interleukin 1; Colitis; Infant; Mevalonate kinase deficiency

Indexed keywords

ACUTE PHASE PROTEIN; ALBUMIN; AMOXICILLIN; CEFOTAXIME; GENTAMICIN; INFLIXIMAB; METHYLPREDNISOLONE; MEVALONATE KINASE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TACROLIMUS;

ARTICLE; BLOOD TRANSFUSION; BLOODY DIARRHEA; CASE REPORT; CHILD; COLON BIOPSY; COLON INJURY; COLON ULCER; COLONOSCOPY; DISEASE SEVERITY; DRUG WITHDRAWAL; ENTEROCOLITIS; FAILURE TO THRIVE; FEMALE; FEVER; GASTRITIS; GENE MUTATION; GENOME ANALYSIS; HEPATOMEGALY; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOALBUMINEMIA; INFANT; INFLAMMATORY INFILTRATE; JEJUNOSTOMY; LABORATORY TEST; LAPAROTOMY; LYMPHOCYTIC INFILTRATION; MALE; MEVALONATE KINASE DEFICIENCY; MEVALONATE KINASE GENE; MOUTH ULCER; ONSET AGE; PERITONEUM ADHESION; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN LOSING GASTROENTEROPATHY; REMISSION; SEQUENCE ANALYSIS; SHOCK; SIGMOIDOSCOPY; TOTAL PARENTERAL NUTRITION; TREATMENT DURATION; ULCERATIVE COLITIS; VOMITING;

ANTI-INTERLEUKIN-1; COLITIS; INFANT; MEVALONATE KINASE DEFICIENCY;

ACUTE-PHASE PROTEINS; COLITIS, ULCERATIVE; COLONOSCOPY; DIARRHEA, INFANTILE; DNA MUTATIONAL ANALYSIS; ENTEROCOLITIS; FAILURE TO THRIVE; FEMALE; FOLLOW-UP STUDIES; HETEROZYGOTE DETECTION; HUMANS; INFANT; INFANT, NEWBORN; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MALE; MEVALONATE KINASE DEFICIENCY; PARENTERAL NUTRITION, TOTAL; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR);

EID: 84884550928     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2012-3344     Document Type: Article

References (13)

1. Van Der Hilst JC, Bodar EJ, Barron KS, et al; International HIDS Study Group. Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore). 2008;87(6):301-310
2. Bader-Meunier B, Florkin B, Sibilia J, et al; SOFREMIP (Société Francophone pour la Rhumatologie et les Maladies Inflammatoires en Pédiatrie); CRI (Club Rhumatismes et Inflammations). Mevalonate kinase deficiency: a survey of 50 patients. Pediatrics. 2011;128(1). Available at: www.pediatrics.org/cgi/content/full/128/1/e152
3. Touitou I, Lesage S, McDermott M, et al. Infevers: an evolving mutation database for auto-inflammatory syndromes. Hum Mutat. 2004;24(3):194-198
4. Cailliez M, Garaix F, Rousset-Rouvière C, et al. Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome-associated febrile crisis. J Inherit Metab Dis. 2006;29(6):763
5. Nimubona L, Laloum D, Rolland MO, Read MH, Guillois B, Duhamel JF. An intestinal obstruction in an eight-month-old child suffering from mevalonic aciduria. Acta Paediatr. 2002;91(6):714-716
6. Ruemmele FM, El Khoury MG, Talbotec C, et al. Characteristics of inflammatory bowel disease with onset during the first year of life. J Pediatr Gastroenterol Nutr. 2006;43(5):603-609
7. Zimmer KP. Inflammatory bowel disease in infants: the other "end of the beginning"? J Pediatr Gastroenterol Nutr. 2006;43(5):566-567
8. Hyams J, Crandall W, Kugathasan S, et al; REACH Study Group. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. Gastroenterology. 2007;132(3):863-873, quiz 1165-1166
9. Hyams J, Damaraju L, Blank M, Johanns J, Guzzo C, Winter HS, et al. Induction and maintenance therapy with infliximab for children with moderate to severe ulcerative colitis. Clin Gastroenterol Hepatol. 2012;10(4):391-399.e1
10. Bodar EJ, Kuijk LM, Drenth JP, Van Der Meer JW, Simon A, Frenkel J. On-demand anakinra treatment is effective in mevalonate kinase deficiency. Ann Rheum Dis. 2011;70(12):2155-2158
11. Mandey SH, Kuijk LM, Frenkel J, Waterham HR. A role for geranylgeranylation in interleukin-1beta secretion. Arthritis Rheum. 2006;54(11):3690-3695
12. Kuijk LM, Beekman JM, Koster J, Waterham HR, Frenkel J, Coffer PJ. HMG-CoA reductase inhibition induces IL-1beta release through Rac1/PI3K/PKB-dependent caspase-1 activation. Blood. 2008;112(9):3563-3573
13. Normand S, Massonnet B, Delwail A, et al. Specific increase in caspase-1 activity and secretion of IL-1 family cytokines: a putative link between mevalonate kinase deficiency and inflammation. Eur Cytokine Netw. 2009;20(3):101-107